Trials / Completed
CompletedNCT04435041
Remote-by-Default Care in the COVID-19 Pandemic
Remote-by-Default Care in the COVID-19 Pandemic: Addressing the Micro-, Meso-, and Macro-level Challenges of a Radical New Service Model
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 103 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
18 month study, funded by ESRC COVID-19 research fund. The aim is to explore and support the rapid shift from face-to-face to remote (telephone and video) conversations in primary care. There are three components: a study of clinical interactions and decision making (micro); four locality-based organisational case studies of new models of care (meso); abd a a study of how digital innovation can support NHS infrastructure and vice versa (macro).
Detailed description
18 month study, funded by ESRC COVID-19 research fund. The aim is to explore and support the rapid shift from face-to-face to remote (telephone and video) conversations in primary care. There are three components: a study of clinical interactions and decision making (micro); four locality-based organisational case studies of new models of care (meso); abd a a study of how digital innovation can support NHS infrastructure and vice versa (macro). The methods are mainly qualitative (interviews, virtual ethnography, analysis of documents, micro-analysis of conversations) and are designed to inform action research. Key deliverables: At least two evidence-based assessment tools: qualitative (questions for remote assessment of breathlessness) and quantitative (a COVID-19-specific early warning score) Transferable lessons about how to achieve rapid spread and scale-up, spread in real time through our extensive intersectoral networks Strengthened infrastructure for supporting digital innovation in the NHS
Conditions
Timeline
- Start date
- 2020-05-13
- Primary completion
- 2021-07-27
- Completion
- 2022-02-28
- First posted
- 2020-06-17
- Last updated
- 2022-04-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04435041. Inclusion in this directory is not an endorsement.